MADIT-II ICD Mortality Benefit Score (MADIT-ICD Benefit Score)
Clinical variables
Enter the baseline characteristics used by the published score.
About the MADIT-ICD Benefit Score
The score integrates predictors of life-threatening VT/VF with predictors of competing non-arrhythmic mortality to support individualized assessment of potential benefit from prophylactic ICD therapy. The original study population comprised patients enrolled in MADIT trials, with external validation in the RAID trial.
Score components
| Component | Predictors | Range |
|---|---|---|
| VT/VF risk | Male sex; age <75; prior NSVT; heart rate >75 bpm; SBP <140 mmHg; LVEF ≤25%; prior MI; atrial arrhythmia. | 0–13 |
| Non-arrhythmic mortality | CRT-D; NYHA ≥II; diabetes; BMI <23 kg/m²; atrial arrhythmia; LVEF ≤25%; age ≥75. | 1–10 |
Benefit-group thresholds used in this implementation
| VT/VF score | Non-arrhythmic score | Group |
|---|---|---|
| >7 | <3 | Highest benefit |
| ≤7 | ≥3 | Lowest benefit |
| Both high or both low | — | Intermediate benefit |
Important: These component-score thresholds classify relative groups; they do not independently establish ICD eligibility. The original study focused on primary-prevention ICD populations, and applicability to other populations should not be assumed.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.